期刊文献+

壳脂胶囊联合多烯磷脂酰胆碱治疗非酒精性脂肪性肝炎38例 被引量:2

下载PDF
导出
摘要 目的:观察壳脂胶囊(主要成分为壳聚糖)联合多烯磷脂酰胆碱(易善复)治疗非酒精性脂肪性肝炎的临床疗效。方法:76例非酒精性脂肪性肝炎患者随机分为治疗组(n=38)和对照组(n=38),治疗组应用壳脂胶囊和易善复片治疗12周,对照组只口服易善复12周,观察治疗前后患者症状及血脂(TG、TC)、肝功能(ALT、AST)及肝脏B超影像图变化。结果:治疗12周后,与对照组相比,治疗组患者TG、TC及肝脏B超影像图变化有统计学意义(P<0·05)。结论:壳脂胶囊和易善复联合治疗可显著降低非酒精性脂肪性肝炎患者TG、TC水平,促进ALT、AST好转,改善肝细胞内脂质沉积,无明显不良反应发生。
出处 《中西医结合肝病杂志》 CAS 2008年第3期171-172,共2页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
  • 相关文献

参考文献6

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1510
  • 2Douglas J. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis, 1998, 138 (2) : 329-334
  • 3Jeon TI, Hwang SG, Park NG, et al. Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. Toxicology, 2003, 187 (1): 67-73
  • 4黎涛,向光明,何东权,彭玲,徐进.壳脂胶囊在非酒精性脂肪性肝炎治疗中的应用[J].四川医学,2007,28(7):724-725. 被引量:8
  • 5Zhang XZ, Gundeman K J, Wu SM, et al. Therapeutic effect of polenepho sphatidylcho line compound in chroic active hepatitisB in a doubleblind randomized con - trolled trials. Chin J Phaimacoepidemiology, 1995, 4 (1): 4-6
  • 6江庆澜,徐邦牢,杨辉,聂玉强,李瑜元.多烯磷脂酰胆碱对非酒精性脂肪肝大鼠的干预效果[J].广州医学院学报,2005,33(4):4-6. 被引量:18

二级参考文献29

  • 1高志强,陆付耳,董慧,徐丽君,王开富,邹欣.二甲双胍干预高脂饲养所致大鼠脂肪肝的研究[J].中华肝脏病杂志,2005,13(2):101-104. 被引量:22
  • 2倪燕君,刘厚钰.非酒精性脂肪肝诊治进展[J].中国临床医学,2004,11(6):942-944. 被引量:16
  • 3胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 4Kawasaki T, Hashimoto N, Kikuchi T, et al. The relationship between fatty liver and hyperinsulinemia in obese Japanese children[J]. J Pediatr Gast Nutr, 1997, 24 (3) :317-321.
  • 5Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabplic syndrome [J]- Diabetes, 2001, 50(8):1844-1850.
  • 6Sanyal AJ, Campbell-sargent C, Mirshahi F, et al. Nonalcoholic steatohepatities [J]. Gastroenterology, 2001, 120(5): 1183 -1192.
  • 7Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 8Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 9Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 10Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.

共引文献1531

同被引文献71

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部